Blue Water Vaccines has signed an option agreement with the UK’s University of Oxford to exclusively license the latter’s novel and potentially revolutionary universal flu vaccine.
News
60% of consultants plan to leave NHS before retirement
The British Medical Association (BMA) has found that as many as 60% of consultants are thinking of leaving the NHS before their planned retirement age.
Pressure on NHS at ‘fever pitch’
The latest NHS monthly performance statistics have shown that pressure on the NHS is at ‘fever pitch’.
UK and Japan collaborate to fight incurable diseases
Medical researchers in the UK and Japan are to join forces in the fight to advance research into treatments for some of the most debilitating degenerative diseases such as diabetes, heart disease and arthritis.
Rise of antibiotic-resistant super-gonorrhoea
Two women in the UK have been infected with so-called super-gonorrhoea, amid an increase in antibiotic resistance.
NHS staff productivity outstrips rest of the economy
New data released by the Office for National Statistics has revealed that NHS productivity for the financial year ending 2017 grew by 3% in England, dramatically outstripping productivity growth in the rest of the economy.
Statins may help treat serious mental illness
Statins could bring significant benefits to people with serious mental illnesses such as schizophrenia, bipolar disorder or non-affective psychoses, indicate new findings from UCL-led research.
Cablivi gets positive results for rare blood clotting disorder
Sanofi’s Cablivi has been linked with a 74% reduction in aTTP-related death in a Phase III trial published by the New England Journal of Medicine.
HRT tablets associated with higher risk of blood clots
New research suggests that hormone replacement therapy (HRT) tablets are associated with a higher risk of rare but serious blood clots.
NICE says Novartis’ migraine drug Aimovig too costly for NHS
The National Institute for Health and Care Excellence (NICE) has rejected NHS funding for Novartis’ Aimovig (erenumab) as preventative treatment for migraine in draft guidelines.
New partnership to test oral paclitaxel
Athenex, Cancer Research UK’s Combinations Alliance and the NIHR Clinical Research Network Industry Alliance have formed a partnership that will test an experimental chemotherapy drug that can be taken orally.
Stivarga final NICE recommendation for hepatocellular carcinoma
Bayer’s Stivarga has received a final green light from the National Institute for Health and Care Excellence (NICE) for use by the NHS to treat advanced liver cancer.
Three men sentenced for supply of illicit meds
Three people have been handed custodial sentences in England for their involvement in the illegal supply of potentially dangerous prescription-only medicines.
Novartis’ crizanlizumab granted FDA Breakthrough Therapy
US regulators have granted Novartis’ crizanlizumab (SEG101) Breakthrough Therapy designation for the prevention of vaso-occlusive crises in patients with sickle cell disease.
Caritas Neuro Solutions & Innvocept team up
Scottish mental health and neurology research company Caritas Neuro Solutions has signed a landmark partnership deal with Mumbai, India-based group Innvocept Solutions.
